Search Results - "Charney, D.S"

Developing cognitive-emotional training exercises as interventions for mood and anxiety disorders by Iacoviello, B.M, Charney, D.S

“…Abstract There is an urgent need for more effective treatments for mood and anxiety disorders. As our understanding of the cognitive and affective neuroscience…”
Get full text

Differenital Behavioral and Neural Consequences of Serotonin and Catecholamine Deficiency in Depression: an Experimental Study by Hasler, G, Homan, P, Neumeister, A, Nugent, A.C, Charney, D.S, Drevets, W.C

“…Introduction Psychopathological and biological markers that predict response to antidepressant drugs that selectively increase serotonin and/or…”
Get full text

Ketamine for treatment-resistant depression: Subjective effects and impact on plasma brain-derived neurotrophic factor by Haile, Colin N, Murrough, J.J, Iosifescu, D.V, Chang, L.C, Jurdi, R.K. Al, Foulkes, A, Iqbal, S, Mahoney, James J, Garza, Richard De La, Charney, D.S, Newton, Thomas F, Mathew, S.J

Get full text

P.245 Intranasal administration of neuropeptide Y; development of a novel treatment for major depressive disorder by Mathé, A.A., Berg, E., Michaneck, M., Charney, D.S., Murrough, J.W.

Get full text

Attention bias away from threat during life threatening danger predicts PTSD symptoms at one-year follow-up by Wald, I., Shechner, T., Bitton, S., Holoshitz, Y., Charney, D.S., Muller, D., Fox, N.A., Pine, D.S., Bar-Haim, Y.

“…Background: Recent studies find a correlation between attentional threat avoidance under stress and posttraumatic stress symptoms. In this study, we assessed…”
Get full text

Neurobiological mechanisms in human anxiety. Evidence supporting central noradrenergic hyperactivity by Charney, D S, Redmond, Jr, D E

“…Preclinical studies in laboratory rodents and non-human primates have led to the hypothesis that noradrenergic hyperactivity is associated with some human…”
Get more information

SPECT imaging of synaptic dopamine release in drug free schizophrenic patients: An experimental validation of the dopamine hypothesis of schizophrenia by Laruelle, M., Abi-Dargham, A., Gil, R., van Dyck, C.H., Erdos, J., D'Souza, D., Rosenblatt, W., McCance-Katz, E., Zea-Ponce, Y., Zoghbi, S.S., Baldwin, R.M., Hoffer, P.B., Krystal, J., Charney, D.S., Innis, R.B.

Get full text

Cortisol response to a cognitive stress challenge in posttraumatic stress disorder (PTSD) related to childhood abuse by Bremner, J.D, Vythilingam, M, Vermetten, E, Adil, J, Khan, S, Nazeer, A, Afzal, N, McGlashan, T, Elzinga, B, Anderson, G.M, Heninger, G, Southwick, S.M, Charney, D.S

“…Preclinical studies show that animals with a history of chronic stress exposure have increased hypothalamic-pituitary-adrenal (HPA) axis reactivity following…”
Get full text

Anxiety disorders: noradrenergic neurotransmission by Neumeister, A, Daher, R J, Charney, D S

“…The past decade has seen a rapid progression in our knowledge of the neurobiological basis of fear and anxiety. Specific neurochemical and neuropeptide systems…”
Get more information

Serotonin transporter binding in major depressive disorder and bipolar disorder assessed using [11C]DASB and positron emission tomography by Cannon, Dara M., Ichise, M., Fromm, S., Nugent, A.C., Rollis, D., Gandhi, S.K., Klaver, J.M., Charney, D.S., Manji, H.K., Drevets, W.C.

“…[...]thirteen MDD-subjects having a history of exposure to serotonin re-uptake inhibitors (SRI) had significantly lower BP in the thalamus (T = 2.03, P =…”
Get full text

459. Psycho-biological indices of special operations selection by Morgan, C.A., Simpson, P., Hazlett, G., Coric, V., Charney, D.S.

Get full text

Serotonin function in anxiety. II. Effects of the serotonin agonist MCPP in panic disorder patients and healthy subjects by Charney, D S, Woods, S W, Goodman, W K, Heninger, G R

“…To assess the role of serotonin function in the development of panic anxiety, the behavioral and biochemical responses to the serotonin receptor agonist,…”
Get full text

Characterization of radioactive metabolites of 5-HT2A receptor pet ligand [18F]altanserin in human and rodent by TAN, P.-Z, BALDWIN, R. M, VAN DYCK, C. H, AL-TIKRITI, M, ROTH, B, KHAN, N, CHARNEY, D. S, INNIS, R. B

“…This study was performed to identify and characterize the radiometabolites of the serotonin 5-HT2A receptor ligand [18F]altanserin in supporting quantification…”
Get full text

Attenuation of ketamine effects in healthy humans by lamotrigine, a drug that reduces glutamate release by Anand, A., Berman, R., Charney, D.S., Krystal, J.H.

Get full text

231. Neuroendocrine and psychobiological responses to uncontrollable stress by Morgan, C.A., Coric, V., Zimolo, Z., Hoyt, G., Wang, S., Hazlett, G., Charney, D.S.

Get full text

268. Simultaneous catecholamine and indoleamine depletion in unmedicated depressed subjects by Berman, R.M., Sanacora, G., Narasimhan, M., Oren, D.A., Cappiello, A., Charney, D.S.

Get full text

218. HPA axis regulation in premenopausal women with PTSD by Rasmusson, A.M., Lipschitz, D.S., Wang, S., Bremner, J.D., Southwick, S.M., Charney, D.S.

Get full text

304. Cortical GABA reduced in unipolar but not bipolar depression by Mason, G.F., Sanacora, G., Anand, A., Epperson, C.N., Goddard, A.W., Rothman, D.L., Charney, D.S., Krystal, J.H.

Get full text

401. One Hertz rTMS of left temporoparietal cortex in schizophrenic patients reporting auditory hallucinations by Hoffman, R.E., Boutros, N.N., Berman, R.M., Hu, S., Rachid, F., Schaffer, N.A., Krystal, J.H., Charney, D.S.

Get full text

322. Transcranial magnetic stimulation in treatment-refractory depression by Berman, R.M., Boutros, N., Narasimhan, M., Sanacora, G., Charney, D.S.

Get full text